TrustCore Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

TrustCore Financial Services’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$764	Hold	100	–	–	﹤0.01%	952
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	982
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	969
2022 Q1	$1K	Hold	100	–	–	﹤0.01%	974
2021 Q4	$3K	Hold	100	–	–	﹤0.01%	830
2021 Q3	$3K	Hold	100	–	–	﹤0.01%	913
2021 Q2	$4K	Hold	100	–	–	﹤0.01%	861
2021 Q1	$4K	Hold	100	–	–	﹤0.01%	802
2020 Q4	$6K	Hold	100	–	–	﹤0.01%	741
2020 Q3	$5K	Hold	100	–	–	﹤0.01%	682
2020 Q2	$5K	Hold	100	–	–	﹤0.01%	697
2020 Q1	$3K	Hold	100	–	–	﹤0.01%	725
2019 Q4	$3K	Sell	100 -500	-83%	-$14.4K	﹤0.01%	775
2019 Q3	$19K	Buy	600 +200	+50%	+$8.16K	﹤0.01%	520
2019 Q2	$19K	Buy	+400	New	+$17.7K	﹤0.01%	512

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TrustCore Financial Services's ADPT Position: Q4 2022 in Review

TrustCore Financial Services held its Adaptive Biotechnologies (ADPT) position steady in Q4 2022 at 100 shares worth $764. The position accounts for ﹤0.01% of the portfolio, ranked #952.

TrustCore Financial Services first reported a position in ADPT in Q2 2019 and has held it in 15 quarters since. The position peaked at $19K in Q3 2019. 223 funds tracked by Wall St. Rank hold ADPT as of Q4 2022.

TrustCore Financial Services held 100 shares of Adaptive Biotechnologies worth $764 as of Q4 2022.
TrustCore Financial Services left its Adaptive Biotechnologies share count unchanged in Q4 2022.
Adaptive Biotechnologies made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #952 holding.
TrustCore Financial Services first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 15 quarters since.
TrustCore Financial Services's Adaptive Biotechnologies position peaked at $19K in Q3 2019.
223 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.